Astellas hires Americas president

pharmafile | October 6, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, brian mclellan 

Astellas has appointed Brian McLellan as the president of Astellas Pharma Technologies in the Americas region.

McLellan is to be responsible for managing all operations at the Norman facilities in Oklahoma in the US, and will report directly to Scott Aladeen, head of the US technology division, president of Astellas US Technologies.

McLellan was promoted to his current position from vice president of technology and operations at Astellas Pharma Technologies. He joined Yamanouchi – one of Astellas’ two founding companies – in 1997 as a project manager in business development.

“Brian has had great success throughout his career at Astellas and his strong leadership skills and experience in the industry will prove to be an asset to the team,” says Aladeen. “Brian will be responsible for ensuring that patients who need our medications will receive the highest quality product possible.”

Related Content

Astellas Pharma to acquire Propella Therapeutics for $175m

Astellas Pharma and Propella Therapeutics have announced that Astellas and Propella have entered a merger …

Astellas plans to invest over €330m in new facility in Ireland

Astellas Pharma has announced that it is preparing to submit a planning application to build …

Astellas set to open new life sciences facilities in Cambridge, Massachusetts

On 9 August 2023, Astellas Pharma announced its plans to open what it has described …

Latest content